Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ACR Committee on Drugs and Contrast Media (2004) Manual on contrast media, 5th edn. American College of Radiology, Reston, VA
Almen T (1994) The etiology of contrast medium reactions. Invest Radiol 19[Suppl]:S37–S45
Ansell G, Tweedie MCK, West CR et al (1980) The current status of reactions to intravenous contrast media. Invest Radiol 15[Suppl]:S32–S39
Bertrand PR, Soyer PM, Rouleau PJ et al (1992) Comparative randomised double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media. Radiology 184:383–384
Bettman MA, Heeren T, Greenfield A, Gondey C (1997) Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology 203:611–620
Bush WH, Swanson DP (1991) Acute reactions to intravascular contrast media: types, risk factors, recognition and specific treatment. AJR Am J Roentgenol 157:1153–1161
Caro JJ, Trindade E, McGregor M (1991) The risks of death and severe nonfatal reactions with high-vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol 156:825–832
Choyke PL, Miller Dl, Lotze MT et al (1992) Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 183:111–114
Cochran ST, Bomyea K, Sayre JW (2001) Trends in adverse events after iv administration of contrast media. AJR Am J Roentgenol 176:1385–1388
Cohan RH, Ellis JH, Dunnick NR (1995) Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology. Radiology 194:357–364
Dawson P (2005) Commentary: repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents. Clin Radiol 60:56–57
Dawson P, Sidhu PS (1993) Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? Clin Radiol 48:225–226
Dore CJ, Sidhu PS, Dawson P (1994) Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? Clin Radiol 49:583–584
Dore CJ, Sidhu PS, Dawson P (1995) Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? Clin Radiol 50:198–199
Fink U, Fink BK, Lissner J (1992) Adverse reactions to nonionic contrast media with special regard to high-risk patients. Eur Radiol 2:317–321
Fischer HW, Doust VL (1972) An evaluation of pretesting in the problem of serious and fatal reactions to excretory urography. Radiology 103:497–501
Fishman JE, Aberle DR, Moldawer NP et al (1991) Atypical contrast reactions associated with systemic interleukin-2 therapy. AJR Am J Roentgenol 156:833–834
Freed KS, Leder RA, Alexander C et al (2001) Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR Am J Roentgenol 176:1389–1392
Greenberger PA, Patterson R (1991) The prevention of immediate generalised reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 87:867–872
Greenberger PA, Patterson R, Radin RR (1984) Two pre-treatment regimens for high-risk patients receiving radiographic contrast media. J Allergy Clin Immunol 74:540–543
Greenberger PA, Patterson R, Tapio CM (1985) Prophylaxis against repeated radiocontrast media reactions in 857 cases. Arch Intern Med 145:2197–2200
Greenberger PA, Meyers SN, Kramer BL et al (1987) Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media. J Allergy Clin Immunol 80:698–702
Hartman GW, Hattery RR, Witten DM, Williamson B (1982) Mortality during excretory urography: Mayo Clinic experience. AJR Am J Roentgenol 139:919–922
Jacobs JE, Birnbaum BA, Langlotz CP (1998) Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 209:411–416
Jordan RM, Mintz RD (1995) Fatal reaction to gadopentetate dimeglumine. AJR Am J Roentgenol 164:734–744
Katayama H, Yamaguchi K, Kozuka T et al (1990) Adverse reactions to ionic and nonionic contrast media. Radiology 175:621–628
King BF (1999) Intravascular contrast media and premedication. In: Bush WH, Krecke KN, King BF, Bettman MA (eds) Radiology life support (RAD-LS): a practical approach. Arnold, London/University Press, New York, p 15
Kirchin MA, Runge VM (2003) Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging 14:426–435
Lang DM, Alpern MB, Visintainer PF, Smith ST (1991) Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers or with asthma. Ann Intern Med 115:270–276
Lasser EC (1985) Etiology of anaphylactoid responses: the promise of nonionics. Invest Radiol 20[Suppl]:S79–S82
Lasser EC (1987) A coherent biochemical basis for increased reactivity to contrast material in allergic patients: a novel concept. AJR Am J Roentgenol 149:1281–1285
Lasser EC (1994) Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? Clin Radiol 49:582–583
Lasser EC (1995) Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? Clin Radiol 50:199
Lasser EC, Berry CC (1994) Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? Clin Radiol 49:584
Lasser EC, Lang JH, Lyon SG (1981) Glucocorticoid-induced elevations of C1-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits. Invest Radiol 16:20–23
Lasser EC, Berry CC, Talner LB et al (1987) Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 317:845–849
Lasser EC, Berry CC, Mishkin MM et al (1994) Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. AJR Am J Roentgenol 162:523–526
Lasser EC, Lyon SG, Berry CC (1997) Reports on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology 203:605–610
Leder R (1997) Letter. AJR Am J Roentgenol 169:906–907
Morcos SK, Thomsen HS, Webb JAW et al (2001) Prevention of generalised reactions to contrast media: a consensus report and guidelines. Eur Radiol 11:1720–1728
Murphy KJ, Brunberg JA, Cohan RH (1996) Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol 167:847–849
Nelson KL, Gifford LM, Lauber-Huber C et al (1995) Clinical safety of gadopentetate dimeglumine. Radiology 196:439–443
Niendorf HP, Haustein J, Cornelius I et al (1991) Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med 22:222–228
Oldham RK, Brogley J, Braud E (1991) J Clin Oncol 8:942–943
Palmer FJ (1988) The RACR survey of intravenous contrast media reactions: final report. Austr Radiol 32:426–428
Radhakrishnan S, Manoharan S, Fleet M (2005) Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents. Clin Radiol 60:58–63
Runge VM (2000) Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 12:205–213
Seymour R, Halpin SF, Hardman JA et al (1994) Corticosteroid prophylaxis in patients with increased risk of adverse reactions to intravascular contrast agents: a survey of current practice in the UK. Clin Radiol 49:791–795
Shehadi WH (1975) Adverse reactions to intravascularly administered contrast media. AJR Am J Roentgenol 124:145–152
Shehadi WH (1985) Death following intravascular administration of contrast media. Acta Radiol Diagn 26:457–461
Siegle RL, Halvorsen RA, Dillon J et al (1991) The use of iohexol in patients with previous reactions to ionic contrast material. Invest Radiol 26:411–416
Thomsen HS, Bush WH (1998) Adverse effects of contrast media: incidence, prevention and management. Drug Safety 19:313–324
Witten DM, Hirsch FD, Hartman GW (1973) Acute reactions to urographic contrast medium. AJR Am J Roentgenol 119:832–840
Wolf GL, Miskin MM, Roux SG et al (1991) Comparison of the rates of adverse drug reactions: ionic contrast agents, ionic agents combined with steroids and nonionic agents. Invest Radiol 26:404–410
Yamaguchi K, Katayama H, Takashima T et al (1991) Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of prestesting. Radiology 178:363–367
Zukiwski AA, David CL, Coan J et al (1990) Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration. Cancer 65:1521–1524
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Webb, J.A.W. (2006). Prevention of Acute Reactions. In: Thomsen, H.S. (eds) Contrast Media. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27742-0_3
Download citation
DOI: https://doi.org/10.1007/3-540-27742-0_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20448-0
Online ISBN: 978-3-540-27742-2
eBook Packages: MedicineMedicine (R0)